NANOSTRUCTURED DRUG MARKET ANALYSIS

Nanostructured Drug Market, by Technology, (Nanoparticles, Nanocrystals, Nanotubes, Liposomes, Micelles, and Others), by Applications (Neurology, Oncology, Cardiovascular/Physiology, Anti-inflammatory/Immunology, Anti-infective, and Others), and by Geography (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) – Size, Share, Outlook, and Opportunity Analysis, 2022-2028

To Be Published : Nov 2024
Code : CMI1841
Formats :
Excel and PDF
Industry : Pharmaceutical

Market Challenges And Opportunities

However, high cost required for the development of nanostructured drugs and safety risks associated with nanostructured drugs such as the duration of time nanoparticles remain in the body, which affects cellular and tissue functions is restraining the market growth.